Cargando…
Lymphoid neogenesis in melanoma: What does it tell us?
Metastatic melanoma lesions sometimes host ectopic lymphoid structures exhibiting ongoing adaptive immune responses. Here, we discuss how this finding fits in our current view of antitumor immunity.
Autores principales: | van Baren, Nicolas, Baurain, Jean-François, Coulie, Pierre G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3583922/ https://www.ncbi.nlm.nih.gov/pubmed/23483539 http://dx.doi.org/10.4161/onci.22505 |
Ejemplares similares
-
Type 2 innate lymphoid cells: a novel actor in anti-melanoma immunity
por: Jacquelot, Nicolas, et al.
Publicado: (2021) -
Expression profile of the human IDO1 protein, a cancer drug target involved in tumoral immune resistance
por: Vigneron, Nathalie, et al.
Publicado: (2015) -
Lymphoid neogenesis in chronic inflammation
por: Pitzalis, C, et al.
Publicado: (2003) -
Scene of the Crime: Where Is GnRH Released, and What Might This Tell Us?
por: Moenter, Suzanne M.
Publicado: (2011) -
What the stock market tells us about the post-COVID-19 world
por: Wagner, Alexander F.
Publicado: (2020)